I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Discovery of TAK-041: a Potent and Selective GPR139 Agonist..:
Holly A. Reichard (2115589)
;
Hans H. Schiffer (10660697)
;
Holger Monenschein (1822072)
...
https://figshare.com/articles/dataset/Discovery_of_TAK-041_a_Potent_and_Selective_GPR139_Agonist_Explored_for_the_Treatment_of_Negative_Symptoms_Associated_with_Schizophrenia/14983813. , 2021
Link:
https://doi.org/10.1021/acs.jmedchem.1c00820.s001
RT Journal T1
Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_14983813&Exemplar=1&LAN=DE A1 Holly A. Reichard (2115589) A1 Hans H. Schiffer (10660697) A1 Holger Monenschein (1822072) A1 Josephine M. Atienza (11134147) A1 Gerard Corbett (11134150) A1 Alton W. Skaggs (11134153) A1 Deanna R. Collia (10660706) A1 William J. Ray (190662) A1 Jordi Serrats (20743) A1 Joshua Bliesath (2115424) A1 Nidhi Kaushal (2449744) A1 Betty P. Lam (11134156) A1 Alejandro Amador-Arjona (11134159) A1 Lisa Rahbaek (11134162) A1 Donavon J. McConn (11134165) A1 Victoria J. Mulligan (11134168) A1 Nicola Brice (11134171) A1 Philip L. R. Gaskin (11134174) A1 Jackie Cilia (2382769) A1 Stephen Hitchcock (2026327) YR 2021 K1 Biochemistry K1 Medicine K1 Cell Biology K1 Molecular Biology K1 Neuroscience K1 Pharmacology K1 Biotechnology K1 Cancer K1 Biological Sciences not elsewhere classified K1 Chemical Sciences not elsewhere classified K1 High-throughput screening K1 GPR 139 agonists K1 chemistry optimization K1 substance-use disorder K1 SCZ K1 compound 56 K1 novel drug K1 vivo efficacy K1 Selective GPR 139 Agonist Explored K1 novel series K1 Negative Symptoms Associated K1 interaction deficits K1 BALB K1 habenula cell activity K1 GPR 139-agonist modulation K1 G-protein-coupled receptor GPR 139 K1 brain nucleus K1 vivo GPR 139 agonist tool compounds K1 GPR 139 agonist TAK -041 K1 NBI -1065846 K1 benzotriazinone-based GPR 139 agonists JF https://figshare.com/articles/dataset/Discovery_of_TAK-041_a_Potent_and_Selective_GPR139_Agonist_Explored_for_the_Treatment_of_Negative_Symptoms_Associated_with_Schizophrenia/14983813 LK http://dx.doi.org/https://doi.org/10.1021/acs.jmedchem.1c00820.s001 DO https://doi.org/10.1021/acs.jmedchem.1c00820.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)